IT201900021693A1 - Derivati butirrati o butirrati e formiati dell’acido ialuronico reticolati e loro procedimento di reticolazione - Google Patents

Derivati butirrati o butirrati e formiati dell’acido ialuronico reticolati e loro procedimento di reticolazione

Info

Publication number
IT201900021693A1
IT201900021693A1 IT102019000021693A IT201900021693A IT201900021693A1 IT 201900021693 A1 IT201900021693 A1 IT 201900021693A1 IT 102019000021693 A IT102019000021693 A IT 102019000021693A IT 201900021693 A IT201900021693 A IT 201900021693A IT 201900021693 A1 IT201900021693 A1 IT 201900021693A1
Authority
IT
Italy
Prior art keywords
butyrated
cross
derivatives
forms
hyaluronic acid
Prior art date
Application number
IT102019000021693A
Other languages
English (en)
Inventor
Marco Mastrodonato
Luca Stucchi
Alessandra Sechi
Fabrizio Picotti
Rita Gianni
Original Assignee
Bmg Pharma S P A
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bmg Pharma S P A filed Critical Bmg Pharma S P A
Priority to IT102019000021693A priority Critical patent/IT201900021693A1/it
Priority to JP2022529349A priority patent/JP2023503887A/ja
Priority to IL293069A priority patent/IL293069A/en
Priority to PCT/IB2020/060888 priority patent/WO2021099977A1/en
Priority to CN202080081262.9A priority patent/CN114727912A/zh
Priority to BR112022009795A priority patent/BR112022009795A2/pt
Priority to US17/756,119 priority patent/US20220411541A1/en
Priority to KR1020227020627A priority patent/KR20220105655A/ko
Priority to MX2022006025A priority patent/MX2022006025A/es
Priority to CA3158866A priority patent/CA3158866A1/en
Priority to EP20823932.7A priority patent/EP4061314A1/en
Priority to AU2020387134A priority patent/AU2020387134A1/en
Publication of IT201900021693A1 publication Critical patent/IT201900021693A1/it
Priority to ZA2022/06756A priority patent/ZA202206756B/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08B—POLYSACCHARIDES; DERIVATIVES THEREOF
    • C08B37/00—Preparation of polysaccharides not provided for in groups C08B1/00 - C08B35/00; Derivatives thereof
    • C08B37/006—Heteroglycans, i.e. polysaccharides having more than one sugar residue in the main chain in either alternating or less regular sequence; Gellans; Succinoglycans; Arabinogalactans; Tragacanth or gum tragacanth or traganth from Astragalus; Gum Karaya from Sterculia urens; Gum Ghatti from Anogeissus latifolia; Derivatives thereof
    • C08B37/0063—Glycosaminoglycans or mucopolysaccharides, e.g. keratan sulfate; Derivatives thereof, e.g. fucoidan
    • C08B37/0072—Hyaluronic acid, i.e. HA or hyaluronan; Derivatives thereof, e.g. crosslinked hyaluronic acid (hylan) or hyaluronates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
    • A61K31/167—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide having the nitrogen of a carboxamide group directly attached to the aromatic ring, e.g. lidocaine, paracetamol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A61K31/726—Glycosaminoglycans, i.e. mucopolysaccharides
    • A61K31/728—Hyaluronic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A61K31/738—Cross-linked polysaccharides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
    • A61K47/56—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule
    • A61K47/61—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule the organic macromolecular compound being a polysaccharide or a derivative thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/02—Cosmetics or similar toiletry preparations characterised by special physical form
    • A61K8/04—Dispersions; Emulsions
    • A61K8/042—Gels
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/72—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
    • A61K8/73—Polysaccharides
    • A61K8/735—Mucopolysaccharides, e.g. hyaluronic acid; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0048—Eye, e.g. artificial tears
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/06—Ointments; Bases therefor; Other semi-solid forms, e.g. creams, sticks, gels
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A61Q19/06—Preparations for care of the skin for countering cellulitis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A61Q19/08—Anti-ageing preparations
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2300/00—Mixtures or combinations of active ingredients, wherein at least one active ingredient is fully defined in groups A61K31/00 - A61K41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
    • A61K2800/80—Process related aspects concerning the preparation of the cosmetic composition or the storage or application thereof
    • A61K2800/91—Injection
IT102019000021693A 2019-11-20 2019-11-20 Derivati butirrati o butirrati e formiati dell’acido ialuronico reticolati e loro procedimento di reticolazione IT201900021693A1 (it)

Priority Applications (13)

Application Number Priority Date Filing Date Title
IT102019000021693A IT201900021693A1 (it) 2019-11-20 2019-11-20 Derivati butirrati o butirrati e formiati dell’acido ialuronico reticolati e loro procedimento di reticolazione
BR112022009795A BR112022009795A2 (pt) 2019-11-20 2020-11-19 Derivados de butirato ou butirato-formato de ligação cruzada do ácido hialurônico e seu processo de ligação cruzada
IL293069A IL293069A (en) 2019-11-20 2020-11-19 History of cross-linked hyaluronic acid butyrate or butyrate-formate and their crosslinking process
PCT/IB2020/060888 WO2021099977A1 (en) 2019-11-20 2020-11-19 Crosslinked butyrate or butyrate-formate derivatives of hyaluronic acid and the crosslinking process thereof
CN202080081262.9A CN114727912A (zh) 2019-11-20 2020-11-19 交联透明质酸丁酸酯或丁酸酯-甲酸酯衍生物及其交联方法
JP2022529349A JP2023503887A (ja) 2019-11-20 2020-11-19 架橋ヒアルロン酸ブチレートまたはブチレート－ホルメート誘導体およびその架橋方法
US17/756,119 US20220411541A1 (en) 2019-11-20 2020-11-19 Crosslinked butyrate or butyrate-formate derivatives of hyaluronic acid and the crosslinking thereof
KR1020227020627A KR20220105655A (ko) 2019-11-20 2020-11-19 가교된 히알루론산 부티레이트 또는 부티레이트-포르메이트 유도체 및 이의 가교 방법
MX2022006025A MX2022006025A (es) 2019-11-20 2020-11-19 Butirato reticulado o derivados de formiato de butirato de acido hialuronico y el proceso de reticulado de los mismos.
CA3158866A CA3158866A1 (en) 2019-11-20 2020-11-19 Crosslinked butyrate or butyrate-formate derivatives of hyaluronic acid and the crosslinking process thereof
EP20823932.7A EP4061314A1 (en) 2019-11-20 2020-11-19 Crosslinked butyrate or butyrate-formate derivatives of hyaluronic acid and the crosslinking process thereof
AU2020387134A AU2020387134A1 (en) 2019-11-20 2020-11-19 Crosslinked butyrate or butyrate-formate derivatives of hyaluronic acid and the crosslinking process thereof
ZA2022/06756A ZA202206756B (en) 2019-11-20 2022-06-17 Crosslinked butyrate or butyrate-formate derivatives of hyaluronic acid and the crosslinking process thereof

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IT102019000021693A IT201900021693A1 (it) 2019-11-20 2019-11-20 Derivati butirrati o butirrati e formiati dell’acido ialuronico reticolati e loro procedimento di reticolazione

Publications (1)

Publication Number Publication Date
IT201900021693A1 true IT201900021693A1 (it) 2021-05-20

Family

ID=69903988

Family Applications (1)

Application Number Title Priority Date Filing Date
IT102019000021693A IT201900021693A1 (it) 2019-11-20 2019-11-20 Derivati butirrati o butirrati e formiati dell’acido ialuronico reticolati e loro procedimento di reticolazione

Country Status (13)

Country Link
US (1) US20220411541A1 (it)
EP (1) EP4061314A1 (it)
JP (1) JP2023503887A (it)
KR (1) KR20220105655A (it)
CN (1) CN114727912A (it)
AU (1) AU2020387134A1 (it)
BR (1) BR112022009795A2 (it)
CA (1) CA3158866A1 (it)
IL (1) IL293069A (it)
IT (1) IT201900021693A1 (it)
MX (1) MX2022006025A (it)
WO (1) WO2021099977A1 (it)
ZA (1) ZA202206756B (it)

Citations (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0341745A1 (en) 1988-05-13 1989-11-15 FIDIA S.p.A. Crosslinked carboxy polysaccharides
WO1997049412A1 (en) * 1996-06-21 1997-12-31 Fidia S.P.A. Autocross-linked hyaluronic acid and related pharmaceutical compositions for the treatment of arthropathies
WO1998023648A1 (en) 1996-11-29 1998-06-04 Societa' Cooperativa Centro Ricerche Poly-Tech A Responsabilita' Limitata New butyric esters with antiproliferative activity and the pharmaceutical compositions containing them
WO2008081255A1 (en) 2006-12-29 2008-07-10 Sigea S.R.L. Derivatives of acid polysaccharides
WO2009068215A1 (en) 2007-11-27 2009-06-04 Sigea S.R.L. Mixed butyric-formic esters of acid polysaccharides, and their preparation and use as skin cosmetics
US20100226988A1 (en) * 2003-04-10 2010-09-09 Allergan, Inc. Cross-linking of low-molecular weight and high-molecular weight polysaccharides, preparation of injectable monophase hydrogels, polysaccharides and hydrogels obtained
EP2614090A2 (en) 2010-09-09 2013-07-17 Altergon S.a. Hybrid cooperative complexes of hyaluronic acid
WO2016113192A1 (en) 2015-01-13 2016-07-21 Sigea S.R.L. Process in water for the preparation of butyric esters of hyaluronic acid sodium salt

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20140256695A1 (en) * 2011-11-11 2014-09-11 Phi Nguyen Injectable filler

Patent Citations (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0341745A1 (en) 1988-05-13 1989-11-15 FIDIA S.p.A. Crosslinked carboxy polysaccharides
WO1997049412A1 (en) * 1996-06-21 1997-12-31 Fidia S.P.A. Autocross-linked hyaluronic acid and related pharmaceutical compositions for the treatment of arthropathies
WO1998023648A1 (en) 1996-11-29 1998-06-04 Societa' Cooperativa Centro Ricerche Poly-Tech A Responsabilita' Limitata New butyric esters with antiproliferative activity and the pharmaceutical compositions containing them
US20100226988A1 (en) * 2003-04-10 2010-09-09 Allergan, Inc. Cross-linking of low-molecular weight and high-molecular weight polysaccharides, preparation of injectable monophase hydrogels, polysaccharides and hydrogels obtained
WO2008081255A1 (en) 2006-12-29 2008-07-10 Sigea S.R.L. Derivatives of acid polysaccharides
US20100292459A1 (en) * 2006-12-29 2010-11-18 Luca Stucchi Derivatives of acid polysaccharides
WO2009068215A1 (en) 2007-11-27 2009-06-04 Sigea S.R.L. Mixed butyric-formic esters of acid polysaccharides, and their preparation and use as skin cosmetics
EP2614090A2 (en) 2010-09-09 2013-07-17 Altergon S.a. Hybrid cooperative complexes of hyaluronic acid
WO2016113192A1 (en) 2015-01-13 2016-07-21 Sigea S.R.L. Process in water for the preparation of butyric esters of hyaluronic acid sodium salt

Also Published As

Publication number Publication date
AU2020387134A1 (en) 2022-06-30
US20220411541A1 (en) 2022-12-29
MX2022006025A (es) 2022-06-22
BR112022009795A2 (pt) 2022-08-16
IL293069A (en) 2022-07-01
WO2021099977A1 (en) 2021-05-27
EP4061314A1 (en) 2022-09-28
CN114727912A (zh) 2022-07-08
KR20220105655A (ko) 2022-07-27
CA3158866A1 (en) 2021-05-27
JP2023503887A (ja) 2023-02-01
ZA202206756B (en) 2023-11-29

Similar Documents

Publication Publication Date Title
CY1123288T1 (el) Συνθεσεις για τροποποιηση της εκφρασης sod-1
CY1122981T1 (el) Συνθεσεις για διαμορφωση της εκφρασης του c9orf72
UY37870A (es) Inhibidores de kras g12c y métodos para utilizarlos campo de la invención
CY1121692T1 (el) Παραγωγα 5-[(πιπεραζιν-1-υλ)-3-οξο-προπυλ]-ιμιδαζολιδινο-2,4-διονης ως αναστολεις adamts για τη θεραπεια οστεοαρθριτιδας
CY1121444T1 (el) Παραγωγα κιnoλonης ως αναστoλεις υποδοχεα αυξητικου παραγοντα ινοβλαστων
MA44991A (fr) Polythérapies d'inhibiteurs de hdac et d'inhibiteurs de pd-1
KR102377234B1 (ko) 중합체 및 절연체 코팅을 갖는 반도체 구조체의 조성물 및 그의 형성 방법
BR112016022871A2 (pt) “equipamento e método para polarizador de guia de onda que compreende uma série de curvas”
CY1122495T1 (el) Ρυθμιστες πυρηνικου υποδοχεα (ror) για τη θεραπεια φλεγμονωδων και αυτοανοσων ασθενειων
IT201600079633A1 (it) Procedimento di preparazione e purificazione del sale sodico dell’acido ialuronico
EA202091731A1 (ru) Ингибиторы аутотаксина и их применения
IL275839A (en) Methods for the treatment of generalized abscess psoriasis using a CCR6 or CXCR2 antagonist
IL270913B (en) Injectable gels containing cross-linked hyaluronic acid and hydroxyapatite and methods for their preparation
DE112018005740A5 (de) Herstellung optoelektronischer Bauelemente
IL281041A (en) Degradable polymeric composition and method for its production
BR112018071854A2 (pt) composição de revestimento aquoso e método de preparação de uma composição de revestimento aquoso
DK3670493T3 (da) Salt af en organisk n,n-dimethylglycinsyreforbindelse og sammensætning og anvendelse deraf
DK3738957T3 (da) Fremgangsmåde til acetylering af cannabinoider
IL286534A (en) Homogeneous injectable gels containing multiple forms of hyaluronic acid and methods for their preparation
IT201900021693A1 (it) Derivati butirrati o butirrati e formiati dell’acido ialuronico reticolati e loro procedimento di reticolazione
DK3700941T3 (da) Fremgangsmåde til fremstilling af modificeret hemicellulose
DK3589606T3 (da) Overgangsmetal-katalyseret protodecarboxylering af alfa-halo-akrylsyrederivater
IT201700045285A1 (it) Trasduttore microelettromeccanico basato su trincea e metodo di fabbricazione del trasduttore microelettromeccanico
SG11202009387UA (en) Use of an ultraviolet radiation absorbing composition as a light stabilizer for a shaped artificial polymer article
IT201900024117A1 (it) Procedimento di sintesi di acido ialuronico reticolato